Development and validation of an early risk-stratification model for hemophagocytic lymphohistiocytosis in severe fever with thrombocytopenia syndrome
PLOS Neglected Tropical Diseases · 17.04.2026 · 20 (4) · e0014247
DOI: 10.1371/journal.pntd.0014247 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 17.04.2026. Verfasst von Yiqiang Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Severe Fever with Thrombocytopenia Syndrome, Lymphohistiocytosis, Hemophagocytic. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Plan of Hainan Province, Natural Science Foundation of Jiangsu Province, grants from the Hainan Province Clinical Medical Center.
Abstract (Originalsprache)
Objective
To develop and validate a model for early risk stratification of secondary hemophagocytic lymphohistiocytosis (HLH) in patients with severe fever with thrombocytopenia syndrome (SFTS).
Methods
This retrospective cohort included adults with laboratory-confirmed SFTS admitted to The First Affiliated Hospital with Nanjing Medical University between January 2019 and July 2024. Predictor variables were derived from clinical and laboratory data obtained within 3 days after virologic confirmation, corresponding to the predefined early-evaluation window of the study. HLH status (binary outcome) was defined using the entire-course HScore (≥170), calculated from the worst available values over the clinical course; HLH-2004 criteria and early-window HScore distributions were summarized descriptively to provide transparent outcome accounting. Twenty-eight candidate predictors entered LASSO with Boruta refinement, and retained variables were used to construct a multivariable logistic model and nomogram. Model performance was evaluated by discrimination, calibration, and decision-curve analysis in the derivation cohort, an internal validation set, and an external cohort of 60 patients from The First Affiliated Hospital with Anhui Medical University.
Results
Among 249 patients (152 non-HLH, 97 HLH), HLH was associated with higher peak temperature, longer fever, more lymphadenopathy/splenomegaly and neurological symptoms, and more severe thrombocytopenia, hypertriglyceridemia, hypofibrinogenemia, hyperferritinemia, higher viral load, elevated muscle/liver enzymes and LDH, and coagulopathy (all p < 0.05). LASSO–Boruta identified six routinely available predictors—peak temperature, splenomegaly, fever duration, triglycerides, fibrinogen, and ferritin. The model showed LR χ² = 214.82 (p < 0.0001), R² = 0.784, C-index = 0.962, Dxy = 0.923, with near-perfect calibration in derivation. In internal validation, discrimination remained near-perfect (AUC 0.997, 95% CI 0.989–1.000); mild miscalibration was corrected by intercept-and-slope recalibration, and decision curves showed net benefit across wide thresholds. External validation (n = 60) confirmed excellent discrimination (AUC 0.907, 95% CI 0.835–0.980), slight miscalibration resolved by recalibration, and preserved net benefit across most thresholds.
Conclusions
A simple model based on early clinical and laboratory variables supports risk stratification for HLH in SFTS and may facilitate closer monitoring, repeated HLH assessment, and timely individualized management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Infectious Disease, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
- Department of Infectious Disease, The First Affiliated Hospital with Anhui Medical University, Hefei, China.
- Department of Infectious and Tropical Diseases, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.
ORCID-Profile: Chuanlong Zhu
Förderung
- Science and Technology Plan of Hainan Province
- Natural Science Foundation of Jiangsu Province
- grants from the Hainan Province Clinical Medical Center
Zitieren
APA
Hu, Y., He, Q., Liu, Y., Kong, J., He, J., Liu, R., Li, W., & Zhu, C. (2026). Development and validation of an early risk-stratification model for hemophagocytic lymphohistiocytosis in severe fever with thrombocytopenia syndrome. PLOS Neglected Tropical Diseases, 20(4), e0014247. https://doi.org/10.1371/journal.pntd.0014247
Vancouver
Hu Y, He Q, Liu Y, Kong J, He J, Liu R, et al. Development and validation of an early risk-stratification model for hemophagocytic lymphohistiocytosis in severe fever with thrombocytopenia syndrome. PLOS Neglected Tropical Diseases. 2026;20(4):e0014247. doi:10.1371/journal.pntd.0014247
BibTeX
@article{Hu2026,
author = {Hu, Yiqiang and He, Qionghan and Liu, Yuxiao and Kong, Jiaqi and He, Jianting and Liu, Rui and Li, Wenting and Zhu, Chuanlong},
title = {Development and validation of an early risk-stratification model for hemophagocytic lymphohistiocytosis in severe fever with thrombocytopenia syndrome},
journal = {PLOS Neglected Tropical Diseases},
year = {2026},
volume = {20},
number = {4},
pages = {e0014247},
doi = {10.1371/journal.pntd.0014247}
}
EUVIMED